InsidersTradesSigma
Total declarations
Companies
▲ Purchases (180 ops.)
▼ Sales (14 ops.)
Insider track record
Board DirectorDisclosed buys
180
Disclosed sells
14
T+90 hit rate
55%
T+90 mean return
+7.8%
Across 76 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by BAKER BROS. ADVISORS LP, Board Member / Investor Representative. Insider active across 26 companies, notably Seagen Inc.. Cumulatively, 304 filings have been logged. Split: 180 buys · 14 sells. Total volume traded: €468.6m. Activity tracked since 14 May 2021. The latest transaction was disclosed on 22 May 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations304 total
400 sharesCommon StockSEC:0001193125-26-294712:0
400 sharesCommon StockSEC:0001193125-26-294712:1
908 sharesCommon StockSEC:0001193125-26-275800:0
908 sharesCommon StockSEC:0001193125-26-275800:1
18,980 sharesOrdinary SharesSEC:0001193125-26-271192:0
18,980 sharesOrdinary SharesSEC:0001193125-26-271192:1
1,642 sharesCommon StockSEC:0001193125-26-265952:0
1,642 sharesCommon StockSEC:0001193125-26-265952:1
6,408 shares0Common StockSEC:0001193125-26-259680:0
6,408 shares0Common StockSEC:0001193125-26-259680:1
6,078 shares0Class A Ordinary SharesSEC:0001193125-26-253615:0
6,078 shares0Class A Ordinary SharesSEC:0001193125-26-253615:1
18,622 shares0Common StockSEC:0001193125-26-253632:0
18,622 shares0Common StockSEC:0001193125-26-253632:1
2,743 shares@ US$23.85120.0002% mcap25.0% of flowOrdinary SharesSEC:0001193125-26-242066:0
2,743 shares@ US$23.85120.0002% mcap25.0% of flowOrdinary SharesSEC:0001193125-26-242066:1
2,756 shares@ US$23.79050.0002% mcap25.0% of flowOrdinary SharesSEC:0001193125-26-242066:2
2,756 shares@ US$23.79050.0002% mcap25.0% of flowOrdinary SharesSEC:0001193125-26-242066:3
19,000 shares0American Depositary SharesSEC:0001193125-26-004828:0
19,000 shares0American Depositary SharesSEC:0001193125-26-004828:1
1,430 shares0Common StockSEC:0000950170-25-089481:0
1,430 shares0Common StockSEC:0000950170-25-089481:1
21,970 shares0Ordinary SharesSEC:0000950170-25-076321:0
953 shares0Common StockSEC:0000950170-25-049450:0
487 shares0Common StockSEC:0000950170-25-049436:0
25 of 304 declarations
About BAKER BROS. ADVISORS LP
Public sources show that Baker Bros. Advisors LP is the investment adviser to affiliated funds with significant holdings in Madrigal Pharmaceuticals, Incyte, Kodiak Sciences, and Bicycle Therapeutics, and that Baker-linked individuals serve on boards at some of these companies. For example, Madrigal and Kodiak proxy materials identify Julian Baker as a director, and Bicycle materials identify Felix Baker as a director and board chair. Public sources do not provide a detailed profile of Baker Bros. Advisors LP as an entity beyond its role as an investor and board representative in these companies. Sources: https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm
